Development of a sensitive PCR-dot blot assay to supplement serological tests for diagnosing Lyme disease
Open Access
- 27 December 2017
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 37 (4) , 701-709
Abstract
Laboratory diagnosis of Lyme disease is difficult and presently dependent on detecting Borrelia burgdorferi-specific antibodies in patient serum with the disadvantage that the immune response to B. burgdorferi can be weak or variable, or alternatively, the slow and inefficient culture confirmation of B. burgdorferi. PCR tests have previously shown poor sensitivity and are not routinely used for diagnosis. We developed a sensitive and specific Lyme Multiplex PCR-dot blot assay (LM-PCR assay) applicable to blood and urine samples to supplement western blot (WB) serological tests for detecting B. burgdorferi infection. The LM-PCR assay utilizes specific DNA hybridization to purify B. burgdorferi DNA followed by PCR amplification of flagellin and OspA gene fragments and their detection by southern dot blots. Results of the assay on 107 and 402 clinical samples from patients with suspected Lyme disease from Houston, Texas or received at the IGeneX laboratory in Palo Alto, California, respectively, were analyzed together with WB findings. The LM-PCR assay was highly specific for B. burgdorferi. In the Texas samples, 23 (21.5%) patients antibody-negative in WB assays by current US Centers for Disease Control (CDC) recommended criteria were positive by LM-PCR performed on urine, serum or whole blood samples. With IGeneX samples, of the 402 LM-PCR positive blood samples, only 70 met the CDC criteria for positive WBs, while 236 met IGeneX criteria for positive WB. Use of the LM-PCR assay and optimization of current CDC serological criteria can improve the diagnosis of Lyme disease.Keywords
This publication has 34 references indexed in Scilit:
- Characterization of Biofilm Formation by Borrelia burgdorferi In VitroPLOS ONE, 2012
- Course of Borrelia burgdorferi DNA Shedding in Urine after TreatmentActa Dermato-Venereologica, 2007
- Importance of Sample Preparation for Molecular Diagnosis of Lyme Borreliosis from UrineJournal of Clinical Microbiology, 2002
- Laboratory Diagnostic Techniques for Patients with Early Lyme Disease Associated with Erythema Migrans: A Comparison of Different TechniquesClinical Infectious Diseases, 2001
- Lyme DiseaseNew England Journal of Medicine, 2001
- Diagnostic Value of PCR for Detection of Borrelia burgdorferi DNA in Clinical Specimens From Patients With Erythema Migrans and Lyme NeuroborreliosisMolecular Diagnosis, 2000
- Borrelia burgdorferi DNA in the urine of treated patients with chronic lyme disease symptoms. A PCR study of 97 casesInfection, 1996
- Target Imbalance: Disparity of Borrelia burgdorferi Genetic Material in Synovial Fluid from Lyme Arthritis PatientsThe Journal of Infectious Diseases, 1994
- Nucleic acid hybridization assays employing dA-tailed capture probesAnalytical Biochemistry, 1989
- Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness.Journal of Clinical Investigation, 1986